| Literature DB >> 35624602 |
Hichem Moulahoum1, Faezeh Ghorbanizamani1, Emine Guler Celik2, Suna Timur1,3.
Abstract
The evolution of biosensors and diagnostic devices has been thriving in its ability to provide reliable tools with simplified operation steps. These evolutions have paved the way for further advances in sensing materials, strategies, and device structures. Polymeric composite materials can be formed into nanostructures and networks of different types, including hydrogels, vesicles, dendrimers, molecularly imprinted polymers (MIP), etc. Due to their biocompatibility, flexibility, and low prices, they are promising tools for future lab-on-chip devices as both manufacturing materials and immobilization surfaces. Polymers can also allow the construction of scaffold materials and 3D structures that further elevate the sensing capabilities of traditional 2D biosensors. This review discusses the latest developments in nano-scaled materials and synthesis techniques for polymer structures and their integration into sensing applications by highlighting their various structural advantages in producing highly sensitive tools that rival bench-top instruments. The developments in material design open a new door for decentralized medicine and public protection that allows effective onsite and point-of-care diagnostics.Entities:
Keywords: nanocomposites; nanoparticles; optical sensing; point-of-care diagnostics; polymer scaffolds
Mesh:
Substances:
Year: 2022 PMID: 35624602 PMCID: PMC9139048 DOI: 10.3390/bios12050301
Source DB: PubMed Journal: Biosensors (Basel) ISSN: 2079-6374
Figure 1Effect of nanofiller materials on polymer nanocomposite properties. Reprinted with permission from ref. [20]. ©2018, Elsevier.
The effect of several nanofillers on the improved properties of polymeric nanocomposites and their sensors.
| Nanofiller | Polymeric Composite | Effect for the Fabricated Composites | Advantages of the Sensors | Ref. |
|---|---|---|---|---|
| Nanoclay | OMMT/PLA | Improved thermal and mechanical property | Improved surface morphology and surface reflectance, modified optical properties | [ |
| Graphene | GC-COOH | Electroactivity | High electroactivity and easy assembly, high sensitivity, | [ |
| CNT | Chitosan modified by ferrocene | Increased surface area and decreased effective distance between mediator molecules | Increased recorded analytical signal, and measurement sensitivity | [ |
| PAMAM dendrimer | PAMAM-PPy | Functionality and increased quantity and homogenous distribution of attached biomolecules | Efficient electron transfer, reversible redox system, and simple reaction procedure | [ |
| Oleic acid-modified MNPs | Magnetic cyclodextrin vesicles | Magnetic property | Higher sensitivity | [ |
| Nano rod and Quantum Dot | TiO2 Nanorod/TiO2 Quantum Dot/Polydopamine | Strong light absorption and excellent | Stronger photoelectric response under visible light | [ |
PLA: Polylactide, OMMT: Organically modified montmorillonite, GC-COOH: Carboxylated chitosan-functionalized nitrogen-containing graphene, CNT: Carbon nanotube, PAMAM-PY: poly(amidoamine) dendrimers and polypyrrole film, MNPs: Magnetic nanoparticles.
Recently developed biosensors based on polymer–biopolymer nanocomposites.
| Polymer/ | Nanocomposites | Target Analyte | Limit of Detection | Sensor Type | Ref. |
|---|---|---|---|---|---|
| Amphiphilic polymer | Polymeric-coated Fe-doped ceria/gold | 2,4-Dinitrophenol | 0.45 μg/mL | Optical biosensor | [ |
| Chitosan | MT/Chitosan | Organo-phosphorus pesticide | 0.448 µg/L | Electrochemical | [ |
| GO/Chitosan | Amine vapors | MA: 2.2 ppm | QCM | [ | |
| AuNP/graphene/ | H2O2 | 1.6 μM | Electrochemical | [ | |
| GNRs/chitosan | Sarcosine | 0.001 μM | [ | ||
| CuS/NSC | Glucose | 2.72 μM | [ | ||
| 3D-NPZnO/Chitosan | 0.2 mM | [ | |||
| AuNP-Chitosan-IL | Malathion | 0.68 nM | [ | ||
| CMC | rGO-CMC | NO and H2O2 | 0.37 μM and 0.08 μM | [ | |
| G4-PAMAM | AuNP/G4-PAMAM dendrimer | Insulin | 0.5 pM | Surface plasmon resonance | [ |
| MWCNTs/G4-PAMAM dendrimer | Cellular prion proteins | 0.5 pM | Electrochemical | [ | |
| PABS | SWCNT/PABS | Hg(II) | 0.06 μM | [ | |
| PAMAM | GO/PAMAM dendrimer | CCRF-CEM cell | 10 cells/mL | [ | |
| PtNP/PAMAM dendrimer | H2O2 | 141 μM | Electrochemiluminescence | [ | |
| PAN | MT/PAN | Glucose | 2.4 mM | Electrochemical | [ |
| AgNO3/PAN nanofiber | Triglyceride | 10.6 mg/dL | [ | ||
| PEI | Au@Ti3C2@PEI-Ru(dcbpy)32+ | SARS-CoV-2 RdRp Gene | 0.21 fM | Electrochemiluminescence | [ |
| PGMA and PEI | Ag-PEI-cPGMA |
| - | Raman scattering | [ |
| poly(N-methylaniline) | poly(N-methylaniline)-Ce2(WO4)3@CNT | Cd2+ | 0.11 nM | Electrochemical | [ |
| Polyrhodanine | Graphene oxide/Fe3O4/ | Doxorubicin | 0.008 μM | [ | |
| PPI | AuNP/PPI dendrimer | ssDNA | 0.05 nM | [ | |
| PS and PANI | Au/PS/PANI | Glucose | 12 μM | [ | |
| PS-b-P4VP | AuNP/PS-b-P4VP | Human IgG | 1.1 nM | Surface plasmon resonance | [ |
| PVP/PVA/PAM | Ti3C2 MXene/PVP/ | Dopamine | 0.2/0.3 | Electrochemical | [ |
3D-NPZnO: 3D-nanoporous Zinc oxide, AuNP: Gold nanoparticle, CCRF-CEM cell: Human acute lymphoblastic leukemia, Ce2(WO4)3: Cerium tungstate, CMC: carboxymethyl cellulose, CuS/NSC: N and S co-doped chitosan polymer, DMA: Dimethylamine, G4-PAMAM: Fourth-generation polyamidoamine dendrimer, GNRs: Graphene nanoribbons, GO: Graphene oxide, IgG: Human gamma globulin, IL: Ionic liquids, MA: Methylamine, MT: Montmorillonite, MWCNT: Multi-walled carbon nanotubes, PABS: Poly (m-amino benzene sulfonic acid), PAN: Polyacrylonitrile, PANI: Polyaniline, PEI: Polyethyleneimine, PGMA: poly(glycidyl methacrylate), PPI: Poly(propyleneimine), PS: Polystyrene, PS-bP4VP: poly(styrene-b-4-vinylpyridine), QCM: Quartz crystal microbalance, rGA: Reduced graphene oxide, SWCNT: Single-walled carbon nanotube, TMA: Trimethylamine.
Various nanoparticles/conducting polymer-based nanocomposites and their characterization techniques, target analyte, and detection limit.
| Conducting Polymer | Nanocomposites | Target Analyte | Limit of Detection | Sensor Type | Ref. |
|---|---|---|---|---|---|
| APS | FcA/APS | H2O2 | 2.07 µM | Electrochemical, Fluorescence | [ |
| P3ABA | Pt@rGO/P3ABA | Glucose | 44.3 µM | Electrochemical | [ |
| Cholesterol | 40.5 µM | ||||
| PABA | G/PABA | Acetylcholine | 2.3 µM | Electrochemical | [ |
| PANI | Au NPs/PANI | Prostate-specific antigen | 0.085 pg/mL | [ | |
| Dopamine | 0.1 µM | [ | |||
| Melamine | 1.39 pM | [ | |||
| Cu-BTC/PANI |
| 2 cfu/mL | [ | ||
| G/PANI | Dopamine | 1.98 pM | [ | ||
| Anthracene | 4.4 nM | [ | |||
| GO/PANI | DNA | 20.8 fM | [ | ||
| NiCo2O4/PANI | Glucose | 0.38 µM | [ | ||
| MWCNTs/PANI | Cholesterol | 0.01 mM | [ | ||
| Cardiac troponin T | 0.04 pg/mL | [ | |||
| NiO/CuO/PANI | Glucose | 2 µM | [ | ||
| NiO/PANI | 0.06 µM | [ | |||
| Pt NPs/PANI | Uric acid | 0.001 mM | [ | ||
| Cholesterol | 0.3 mM | [ | |||
| Triglyceride | 0.2 mM | [ | |||
| ZnO/MWCNTs/PANI | Glucose | 0.1 mM | [ | ||
| G/PANI | Estradiol | 0.02 ng/mL | Immunosensor | [ | |
| PANI@PPY | MWCNTs/PANI@PPY | H2O2 | 0.1 µM | Electrochemical | [ |
| PDA | MWCNTs/PDA | Cholesterol (Ch) (Ch oxidase/SPE) | 1.5 µM | Electrochemical | [ |
| PEDOT | Au NPs/PEDOT | Triglyceride | 89 µM | [ | |
| CA15-3 | 35.64 mU/mL | [ | |||
| CNTs/PEDOT | Dopamine | 20 nM | [ | ||
| AuNPs-MWCNT/PEDOT | Catechol | 0.11 µM | [ | ||
| Laccase | 12.26 µM | ||||
| CNTs/PEDOT |
| 0.5 fg/mL | [ | ||
| Fe2O3/PEDOT | Carcinoembryonic antigen | - | Electrochemical paper-based | [ | |
| GO/PEDOT | Dopamine | 90 nM | Electrochemical | [ | |
| MWCNTs/PEDOT | Magnolol | 3 nM | [ | ||
| PtNPs-PEDOT | Glucose | 1.55 µM | [ | ||
| RGO/PEDOT | Dopamine | 78 fM | [ | ||
| 39 nM | [ | ||||
| ZrO2/PEDOT | Vitamin B2 | 0.012 µM | [ | ||
| Vitamin B6 | 0.2 µM | ||||
| Vitamin C | 0.45 µM | ||||
| PIn-5-COOH | MWCNTs/PIn-5-COOH | α-fetoprotein | 0.33 pg/mL | Immunosensor | [ |
| POT | Au NPs/POT | Glucose | 0.2 mM | Electrochemical | [ |
| PP3C | GO/PP3C | Glucose | 0.05 mM | Electrochemical | [ |
| PPy | Ag@ZnO/PPy | Xanthine (X) | 0.07 µM | [ | |
| Au NPs/PPy | Carcinoembryonic antigen | 1.6 × 10−7 ng/ml | Immunosensor | [ | |
| Dopamine | 1.5 × 10−8 M | Electrochemical | [ | ||
| Serotonin | 1.0 × 10−9 M | ||||
| DNA | 8.4 × 10−12 M | [ | |||
| CeO2-NRs/Ppy | DNA from | 0.29 vM | [ | ||
| Ferrocene/PPY |
| 0.36 aM | [ | ||
| G/PPy | Adenine | 0.02 µM | [ | ||
| Guanine | 0.01 µM | ||||
| MWCNTs/PPy | 6-mercaptopurine | 0.08 µM | [ | ||
| Glucose | 0.43 µM | [ | |||
| NiO/PPy | Glucose | 0.33 µM | [ | ||
| NiCo2O4/PPy | 0.22 µM, | [ | |||
| ZnFe2O4/PPy | 0.1 mM | [ | |||
| PTBA | S, N-doped carbon/PTBA | Neurotransmitters | 0.034 nM | Electrochemical | [ |
| PVDF | Carbon black/PVDF | IL-8 biomarker | 3.3 fg/mL | Immunosensor | [ |
AgNPs: Silver nanoparticles, APS: Amino-polyethersulfone, Au NPs: Gold nanoparticles, BTC: 1,3,5-benzene tricarboxylic acid, CeO2: Cerium oxide, CNTs: Carbon nanotubes, Cu: copper, FcA: ferrocene carboxylic acid, Fe2O3: Iron (II, III) oxide, G: Graphene, GO: Graphene oxide, MWCNT: Multi-walled carbon nanotubes, NiCo2O4: Nickel cobaltite, NiO: Nickel oxide, P3ABA: Poly(3-aminobenzoic acid), PABA: Poly(3-amino-benzylamine-co-aniline), PANI: Polyaniline, PDA: Polydopamine, PEDOT: Poly(3,4-ethylene dioxythiophene), PIn-5-COOH: Poly(indole-5-carboxylic acid), PP3C: Poly(pyrrole-3-carboxylic acid), PPY: Polypyrrole, Pt NPs: Platinum nanoparticles, PTBA: Poly 2, 2′:5′, 5″-terthiophene-3′-p-benzoic acid, PVDF: Polyvinylidene fluoride, RGO: Reduced graphene oxide, TiO2: Titanium dioxide, ZnO: Zinc oxide, ZrO2: Zirconium dioxide.
Some nanomaterials combining MIP architectures for biosensor applications.
| MIP Nanocomposite | Target Analyte | Limit of Detection | Sensor Type | Ref. |
|---|---|---|---|---|
| AgNWs-MIPs | Lactate | 0.22 μM | Electrochemical | [ |
| AuNPs-GO-MIP | BRCA1 gene | 2.53 fM | [ | |
| bAu@mSiO2@MIP | Enrofloxacin | 1.5 nM | Optical biosensor | [ |
| CdS/CdTe QDs/MIP | BSA | 0.5 μM | [ | |
| Fe3O4-MIP | Tributyltin | 5.37 pM | Electrochemical | [ |
| fMWCNTs-MIP | Norfloxacin | 1.58 nM | [ | |
| GO-MIP | Cholesterol | 0.1 nM | [ | |
| MIP@CdTe QDs | Lysozyme | 3.2 μg/mL | Optical biosensor | [ |
| MWCNT-MIP | Chlorpromazine | 0.29 nM | Electrochemical | [ |
| MWCNTs-Chit-MIP | HCV antigen | 1.67 fg/mL | [ | |
| PGr/CdTe QDs/Fe3O4@SiO2/MIP | Cefoperazone | 0.09 μg/L | Optical biosensor | [ |
| SiC-MIP | Loratadine | 0.15 μM | Electrochemical | [ |
| SMoSe2/NSG/Au/MIPs | Dopamin | 0.02 μM | [ |
bAu@mSiO2@MIP: Multibranched gold−silica−molecularly imprinted polymer, BRCA1: Breast cancer susceptibility gene, BSA: Bovine serum albumin, GO: Graphene oxide, HCV: Hepatitis C virus, MWCNT: Multi-walled carbon nanotube, SiC: Silicon carbide nanoparticles.
Figure 2Typical 3D architectures used in biosensors, including roughness enhancement, topographical structures, fiber networks, etc. Molecularly imprinted polymers can be used in four steps: Assembly (1), deposition and polymerization (2), removal (3), and back to the initial step (4). Adapted with permission from Ref. [169]. ©2019, Elsevier B.V.
Figure 3TiO2/agarose hybrid gel and the recycling and recovery of TiO2 nanoparticles through heating and separation techniques. Adapted with permission from Ref. [201]. ©2017, Royal Society of Chemistry.
Collection of some of the pertinent nanocomposite hydrogel applications for biosensing.
| Additives | Analyte | Sensing Method | LOD | Ref. |
|---|---|---|---|---|
| Ag NPs@PEG | Fe3+ | Fluorescence | 45 µM | [ |
| Thiosulfate | 60 µM | |||
| ALP | Vanadium | Electrochemical | 230 nM | [ |
| Aptamer@carboxylated PPy nanotubes | Dopamine | Electrochemical | 1.0 nM | [ |
| Au nanorod@SiNP-doped TiO2-chitosan | Dichlovos | Electrochemical | 5.3 nM | [ |
| Fenthion | 1.3 nM | |||
| Au NPs | Glucose | Electrochemical | 370 nM | [ |
| AuNCs modified DNA-aptamer | Progesterone (P4) | Electrochemical | 1.0 ng/mL | [ |
| Carbon dots | microRNA-21 in breast cancer cells | Fluorescence | 0.03 fM | [ |
| Carbon-encapsulated Fe3O4 NPs@PAAm | Formaldehyde | Colorimetric | - | [ |
| CNCs | Strain sensor | Electrochemical | - | [ |
| Co3O4@GO | Glucose | Electrochemical (Voltammeter) | 250 µM | [ |
| Fe3O4@SiO2(F)@meso-SiO2 nanoparticles | glucose | Fluorescence quenching | 0.46 mM | [ |
| GO | Glucose | Optical, Electrochemical | 25 µM | [ |
| Biochemical oxygen demand | Fluorescent | 0.4 mg | [ | |
| Antibiotic | 25 mg/L | [ | ||
| Strain sensor | Electrochemical | - | [ | |
| GO/PANI | BSA | Near-infrared light-responsive electrochemical | 15 nM | [ |
| Ionic liquid hydrogel-Au nanoballs-MoSe2 | Carcinoembryonic antigen (CEA) | Photo-electrochemical (Photocurrent) | 11.2 nM | [ |
| Ionic liquid-AuNP and ZnCdHgSe QDs | Human epididymis protein 4 (HE4) | 15.4 nM | [ | |
| Laponite@VBA | Glucose | Electrochemical (Current) | 200 mM | [ |
| Lignocellulose nanofibers/LC | Strain and pressure sensor | Electrochemical | - | [ |
| MSA-capped CdTe QDs | Dopamine | Fluorescent | 50 nM | [ |
| N-doped porous carbons | Acetaminophen | Electrochemical | 1.2 nM | [ |
| NiCo2O4 nanoflowers@3D nitrogen-doped graphene | Glucose | Optical, Electrochemical | 390 µM | [ |
| Hydroperoxide | 136 µM | |||
| PANI | Ascorbic acid | Spectrometric (Infrared) | 1.28 mM | [ |
| Dopamine | 44 µM | |||
| Uric acid | Electrochemical | 46 µM | ||
| Xanthine | Optical | 9.6 nM | [ | |
| Pd@Au NPs | microRNA let-7a | Electrochemiluminescence | 1.49 fM | [ |
| PDA@Ag NPs | Epidermal | Electrical | - | [ |
| PEDOT/PSS | Strain sensor | Electrochemical | - | [ |
| PEG@ CdSe/ZnS QDs | Phenol | Fluorescence quenching | 1.0 mM | [ |
| PEG@Ag NW | neuronal stem cells (NSC)-derived neural differentiation | Fluorescent | Neurite length (30–140 mm) | [ |
| Plasmonic silver nanocubes | Glucose | Optical | 2.29 mM | [ |
| PPy | Electrochemical (Amperometry) | 4.0 µM | [ | |
| Pt NPs@3D graphene | Electrochemical (Voltammeter) | 5.0 mM | [ | |
| Pt NPs@PANI | Triglycerides | Electrochemical (Amperometry) | 70 µM | [ |
| Lactate | 60 µM | |||
| Glucose | 200 µM | |||
| Uric acid | 70 µM | [ | ||
| Cholesterol | 300 µM | |||
| Triglycerides | 200 µM | |||
| SA-B-DAPPy | Strain sensor | Electrochemical | - | [ |
| SiO2 | Strain and pressure sensor | - | [ | |
| TEGO | Human-body motion and glucose | Electrochemical and mechanical | 200 nM | [ |
| Thioglycolic acid-QDs and N-Acetyl-l-cysteine-QDs | Fe3+ ion | Optical, Fluorescent | 14 nM | [ |
Ag NPs: Silver nanoparticles, Ag NW: silver nanowire, ALP: Alkaline phosphatase, Au NPs: Gold nanoparticles, BSA: Bovine serum albumin, CdSe: Cadmium selenide, CdTe: Cadmium telluride, CNCs: Cellulose nanocrystals, Co3O4: Cobaltosic oxide, Fe3O4: Iron(II, III) oxide, GO: Graphene oxide, LC: Lignin-based carbon, MoSe2: Molybdenum diselenide, MSA: Mercaptosuccinic acid, NiCo2O4: Nickel cobaltite, PAAm: poly(acrylamide), PANI: Poly(aniline), PDA: Polydopamine, PEDOT/PSS: Poly(3,4-ethlenedioxythiophene)/poly(styrenesulfonate), PEG: Poly(ethylene glycol), PPy: Poly(pyrrole), Pt NPs: Platinum nanoparticles, PVA: polyvinyl alcohol, QDs: Quantum dots, SA-B-DAPPy: Sodium alginate (SA) and dopamine functionalized polypyrrole, Si NPs: Silicon nanoparticles, SiO2: Silicon dioxide, TEGO: thermally exfoliated graphene oxide, TiO2: Titanium dioxide, VBA: vinylbenzyl triethylammonium chloride, ZnCdHgSe: Zinc cadmium mercury and selenium, ZnS: Zinc sulfide.